Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2026)

Kiniksa Pharmaceuticals International has reported Inventory Average for 6 years, with the latest figure at $64.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 164.36% year-over-year to $64.0 million; the trailing twelve-month figure through Mar 2026 stood at $64.0 million (up 164.36% YoY), and the FY2025 full-year result was $40.6 million, up 41.35% from the prior year.
• Inventory Average for Q1 2026 stood at $64.0 million, up from $48.1 million in the prior quarter.
• The five-year high for Inventory Average was $64.0 million in Q1 2026, with the low at $8.4 million in Q1 2022.
• Historically, Inventory Average has averaged $29.2 million across 5 years, with a median of $27.5 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average surged 290.26% — and 2025, when it fell 17.07%.
• Kiniksa Pharmaceuticals International's Inventory Average stood at $18.1 million in 2022, then jumped by 56.56% to $28.4 million in 2023, then dropped by 2.93% to $27.5 million in 2024, then soared by 74.93% to $48.1 million in 2025, then surged by 32.97% to $64.0 million in 2026.
• The last three Inventory Average figures came in at $64.0 million (Q1 2026), $48.1 million (Q4 2025), and $44.8 million (Q3 2025), per Business Quant data.